Malignant perivascular epithelioid cell tumor of the retroperitoneum

被引:1
作者
Wu, Ji-Hua [1 ]
Zhou, Jin-Lian [1 ]
Cui, Yan [2 ]
Jing, Qing-Ping [1 ]
Shang, Le [1 ]
Zhang, Jian-Zhong [1 ]
机构
[1] PLA, Dept Pathol & Expt Med, Hosp 306, Beijing 100101, Peoples R China
[2] PLA, Dept Gen Surg, Hosp 306, Beijing 100101, Peoples R China
关键词
Retroperitoneum; perivascular epithelioid cell tumors; clinicopathology; OF-THE-LITERATURE; MTOR INHIBITION; PECOMAS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Perivascular epithelioid cell tumors (PEComas) are a rare type of mesenchymal neoplasms characterized by a proliferation of perivascular cells with an epithelioid phenotype and expression of myo-melanocytic markers. The majority of PEComas seem to be benign and usually their prognosis is good. Malignant cases are extremely rare, exhibiting a malignant course with local recurrences and distant metastases. We herein report a case of a malignant PEComa arising in the retroperitoneum. The patient was a 55-year-old woman experiencing abdominal discomfort for approximately one month. Ultrasound and computer tomography (CT) scans of the abdomen revealed a solid mass arising from the retroperitoneum. Microscopically, the tumor was composed of epithelioid cells mixed with spindled cells. The nucleus had significant atypia, and the mitoses were obvious. The focal intravascular tumor embolus was visible. Immunohistochemically, the epithelioid tumor cells were positive for HMB45 and Melan-A, and the spindled tumor cells were positive for SMA and desmin. Seven months after a surgical resection, an ultrasound revealed liver metastases. In conclusion, the malignant PEComas of the retroperitoneum is a very rare neoplasm with unique morphological and immunohistochemical characteristics. It should be differentiated from other epithelioid cell tumors of the retroperitoneum.
引用
收藏
页码:2251 / 2256
页数:6
相关论文
共 19 条
[1]  
Armah HB, 2009, ARCH PATHOL LAB MED, V133, P648, DOI 10.1043/1543-2165-133.4.648
[2]   Malignant perivascular epithelioid cell tumor of the uterus [J].
Bleeker, Jonathan S. ;
Quevedo, J. Fernando ;
Folpe, Andrew L. .
RARE TUMORS, 2012, 4 (01) :45-48
[3]  
Bleeker Jonathan S., 2012, Sarcoma, V2012, P541626, DOI 10.1155/2012/541626
[4]   Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosis [J].
Bonetti, F ;
Martignoni, G ;
Colato, C ;
Manfrin, E ;
Gambacorta, M ;
Faleri, M ;
Bacchi, C ;
Sin, VC ;
Wong, NL ;
Coady, M ;
Kwok-cheung, JC .
MODERN PATHOLOGY, 2001, 14 (06) :563-568
[5]   Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: Clinical and molecular correlates [J].
Dickson, Mark A. ;
Schwartz, Gary K. ;
Antonescu, Cristina R. ;
Kwiatkowski, David J. ;
Malinowska, Izabela A. .
INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (07) :1711-1717
[6]  
Folpe A., 2002, World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, P221
[7]   Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin - A clinicoplathologic study of 26 cases and review of the literature [J].
Folpe, AL ;
Mentzel, T ;
Lehr, HA ;
Fisher, C ;
Balzer, BL ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (12) :1558-1575
[8]   Perivascular epithelioid cell neoplasm of the colon [J].
Freeman, Hugh James ;
Webber, Doug L. .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2010, 2 (04) :205-208
[9]   Malignant perivascular epithelioid cell tumor of mesentery with lymph node involvement: a case report and review of literature [J].
Fu, Xinge ;
Jiang, Ju-hong ;
Gu, Xia ;
Li, Zhi .
DIAGNOSTIC PATHOLOGY, 2013, 8
[10]   Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor [J].
Gennatas, Constantine ;
Michalaki, Vasiliki ;
Kairi, Paraskevi Vasilatou ;
Kondi-Paphiti, Agathi ;
Voros, Dionysios .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10